IL6 and diabetes mellitus: Chronic low-grade inflammation—marked by elevated production of pro-inflammatory cytokines such as interleukin (IL)-6, IL-1β, and tumour necrosis factor-α (TNF-α)—is a typical feature of patients with DM [41].